These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 10555992

  • 1. Quantitative and qualitative signals determine T-cell cycle entry and progression.
    Modiano JF, Mayor J, Ball C, Chitko-McKown CG, Sakata N, Domenico-Hahn J, Lucas JJ, Gelfand EW.
    Cell Immunol; 1999 Oct 10; 197(1):19-29. PubMed ID: 10555992
    [Abstract] [Full Text] [Related]

  • 2. Signals involved in T cell activation. II. Distinct roles of intact accessory cells, phorbol esters, and interleukin 1 in activation and cell cycle progression of resting T lymphocytes.
    Davis L, Lipsky PE.
    J Immunol; 1986 May 15; 136(10):3588-96. PubMed ID: 3486215
    [Abstract] [Full Text] [Related]

  • 3. A cytokine, lymphocyte blastogenesis inhibitory factor (LBIF), arrests mitogen-stimulated T lymphocytes at early G1 phase with no influence on interleukin 2 production and interleukin 2 receptor light chain expression.
    Sugimura K, Ueda Y, Takeda K, Fukuda S, Tsukahara K, Habu Y, Fujiwara H, Azuma I.
    Eur J Immunol; 1989 Aug 15; 19(8):1357-64. PubMed ID: 2673797
    [Abstract] [Full Text] [Related]

  • 4. Interferon-alpha inhibits proliferation in human T lymphocytes by abrogation of interleukin 2-induced changes in cell cycle-regulatory proteins.
    Erickson S, Sangfelt O, Castro J, Heyman M, Einhorn S, Grandér D.
    Cell Growth Differ; 1999 Aug 15; 10(8):575-82. PubMed ID: 10470857
    [Abstract] [Full Text] [Related]

  • 5. [The surface expression of CD25 at different stages of proliferative response in human lymphocytes. II. The role of interleukin-2].
    Shatrova AN, Zenin VV, Aksenov ND, Mitiushova EV, Marakhova II.
    Tsitologiia; 2011 Aug 15; 53(8):652-8. PubMed ID: 21961284
    [Abstract] [Full Text] [Related]

  • 6. Role of mitogen-activated protein kinases in Thy-1-induced T-lymphocyte activation.
    Conrad DM, Furlong SJ, Doucette CD, Boudreau RT, Hoskin DW.
    Cell Signal; 2009 Aug 15; 21(8):1298-307. PubMed ID: 19324083
    [Abstract] [Full Text] [Related]

  • 7. IL-2-mediated cell cycle progression and inhibition of apoptosis does not require NF-kappa B or activating protein-1 activation in primary human T cells.
    Iacobelli M, Rohwer F, Shanahan P, Quiroz JA, McGuire KL.
    J Immunol; 1999 Mar 15; 162(6):3308-15. PubMed ID: 10092783
    [Abstract] [Full Text] [Related]

  • 8. Ryanodine receptor signaling is required for anti-CD3-induced T cell proliferation, interleukin-2 synthesis, and interleukin-2 receptor signaling.
    Conrad DM, Hanniman EA, Watson CL, Mader JS, Hoskin DW.
    J Cell Biochem; 2004 May 15; 92(2):387-99. PubMed ID: 15108363
    [Abstract] [Full Text] [Related]

  • 9. Promotion of human T lymphocyte proliferation by IL-4.
    Mitchell LC, Davis LS, Lipsky PE.
    J Immunol; 1989 Mar 01; 142(5):1548-57. PubMed ID: 2783946
    [Abstract] [Full Text] [Related]

  • 10. Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle.
    Terada N, Lucas JJ, Szepesi A, Franklin RA, Domenico J, Gelfand EW.
    J Cell Physiol; 1993 Jan 01; 154(1):7-15. PubMed ID: 8419408
    [Abstract] [Full Text] [Related]

  • 11. Sensitivity of IL-5 production to the cAMP-dependent pathway in human T cells is reduced by exogenous IL-2 in a phosphoinositide 3-kinase-dependent way.
    Heijink IH, Kauffman HF, Postma DS, de Monchy JG, Vellenga E.
    Eur J Immunol; 2003 Aug 01; 33(8):2206-15. PubMed ID: 12884295
    [Abstract] [Full Text] [Related]

  • 12. Anti-CD3-stimulated Ca2+ signal in individual human peripheral T cells. Activation correlates with a sustained increase in intracellular Ca2+1.
    Wacholtz MC, Lipsky PE.
    J Immunol; 1993 Jun 15; 150(12):5338-49. PubMed ID: 8515062
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation.
    Powell JD, Lerner CG, Schwartz RH.
    J Immunol; 1999 Mar 01; 162(5):2775-84. PubMed ID: 10072524
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treponema denticola immunoinhibitory protein induces irreversible G1 arrest in activated human lymphocytes.
    Lee W, Pankoski L, Zekavat A, Shenker BJ.
    Oral Microbiol Immunol; 2004 Jun 01; 19(3):144-9. PubMed ID: 15107064
    [Abstract] [Full Text] [Related]

  • 16. Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals.
    Shipp MA, Reinherz EL.
    J Immunol; 1987 Oct 01; 139(7):2143-8. PubMed ID: 2821108
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Human T cells require IL-2 but not G1/S transition to acquire susceptibility to Fas-mediated apoptosis.
    Fournel S, Genestier L, Robinet E, Flacher M, Revillard JP.
    J Immunol; 1996 Nov 15; 157(10):4309-15. PubMed ID: 8906804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.